Search research articles
Contact Us
Filters
Showing results (141-150 of 159) with videos related to
Page
of 16
Sort By:
The EMBO Journal
|
September 14, 2010
Cooperative functions of Chk1 and Chk2 reduce tumour susceptibility in vivo
Hiroyuki Niida, Kazuhiro Murata, Midori Shimada, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 30, 2003
Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data
Denise L Doolan, Scott Southwood, Daniel A Freilich, et al.
Cancer Cell
|
October 7, 2008
Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice
Rui-Hong Wang, Kundan Sengupta, Cuiling Li, et al.
ACS Pharmacology & Translational Science
|
November 14, 2024
Covalent Modification of p53 by (<i>E</i>)-1-(4-Methylpiperazin-1-yl)-3-(5-nitrofuran-2-yl)prop-2-en-1-one
Kate Brown, Marco Robello, Andrew J Perciaccante, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 15, 2018
Intensity and duration of TCR signaling is limited by p38 phosphorylation of ZAP-70<sup>T293</sup> and destabilization of the signalosome
Maria Letizia Giardino Torchia, Debjani Dutta, Paul R Mittelstadt, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 9, 2003
Nitric oxide-induced cellular stress and p53 activation in chronic inflammation
Lorne J Hofseth, Shin'ichi Saito, S Perwez Hussain, et al.
Journal of Proteome Research
|
November 4, 2006
Proteomic and bioinformatic characterization of the biogenesis and function of melanosomes
An Chi, Julio C Valencia, Zhang-Zhi Hu, et al.
Structure (London, England : 1993)
|
February 5, 2015
An acetyl-methyl switch drives a conformational change in p53
Qiong Tong, Sharlyn J Mazur, Hector Rincon-Arano, et al.
Frontiers in Oncology
|
January 30, 2023
Targeting mutant p53-R248W reactivates WT p53 function and alters the onco-metabolic profile
Kate Brown, Lisa M Miller Jenkins, Daniel R Crooks, et al.
Cancer Cell
|
January 11, 2017
Epigenetic siRNA and Chemical Screens Identify SETD8 Inhibition as a Therapeutic Strategy for p53 Activation in High-Risk Neuroblastoma
Veronica Veschi, Zhihui Liu, Ty C Voss, et al.
Page
of 16
Search research articles
Search
Showing results (141-150 of 159) with videos related to
Sort By:
Page
of 16
The EMBO Journal
|
September 14, 2010
Cooperative functions of Chk1 and Chk2 reduce tumour susceptibility in vivo
Hiroyuki Niida, Kazuhiro Murata, Midori Shimada, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 30, 2003
Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data
Denise L Doolan, Scott Southwood, Daniel A Freilich, et al.
Cancer Cell
|
October 7, 2008
Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice
Rui-Hong Wang, Kundan Sengupta, Cuiling Li, et al.
ACS Pharmacology & Translational Science
|
November 14, 2024
Covalent Modification of p53 by (<i>E</i>)-1-(4-Methylpiperazin-1-yl)-3-(5-nitrofuran-2-yl)prop-2-en-1-one
Kate Brown, Marco Robello, Andrew J Perciaccante, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 15, 2018
Intensity and duration of TCR signaling is limited by p38 phosphorylation of ZAP-70<sup>T293</sup> and destabilization of the signalosome
Maria Letizia Giardino Torchia, Debjani Dutta, Paul R Mittelstadt, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 9, 2003
Nitric oxide-induced cellular stress and p53 activation in chronic inflammation
Lorne J Hofseth, Shin'ichi Saito, S Perwez Hussain, et al.
Journal of Proteome Research
|
November 4, 2006
Proteomic and bioinformatic characterization of the biogenesis and function of melanosomes
An Chi, Julio C Valencia, Zhang-Zhi Hu, et al.
Structure (London, England : 1993)
|
February 5, 2015
An acetyl-methyl switch drives a conformational change in p53
Qiong Tong, Sharlyn J Mazur, Hector Rincon-Arano, et al.
Frontiers in Oncology
|
January 30, 2023
Targeting mutant p53-R248W reactivates WT p53 function and alters the onco-metabolic profile
Kate Brown, Lisa M Miller Jenkins, Daniel R Crooks, et al.
Cancer Cell
|
January 11, 2017
Epigenetic siRNA and Chemical Screens Identify SETD8 Inhibition as a Therapeutic Strategy for p53 Activation in High-Risk Neuroblastoma
Veronica Veschi, Zhihui Liu, Ty C Voss, et al.
Page
of 16